David Li
Stock Analyst at Bank of America Securities
(2.39)
# 3,045
Out of 5,073 analysts
102
Total ratings
50%
Success rate
1.6%
Average return
Main Sectors:
Stocks Rated by David Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 6160 BeOne Medicines AG | Reiterated: Buy | $243.80 → $255.43 | $226.00 | +13.02% | 2 | Aug 6, 2026 | |
| ONC BeOne Medicines AG | Reiterated: Buy | $402 → $423 | $386.46 | +9.46% | 35 | Aug 6, 2026 | |
| ZLAB Zai Lab | Reiterated: Hold | $22 → $22 | $24.20 | -10.74% | 41 | May 21, 2026 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Reiterated: Buy | $38.00 → $56.00 | $38.56 | n/a | 2 | Aug 29, 2025 | |
| HKG: 1801 Innovent Biologics, Inc. | Reiterated: Buy | $56.90 | $83.60 | n/a | 1 | Jan 3, 2025 | |
| HKG: 2607 Shanghai Pharmaceuticals Holding Co., Ltd | Reiterated: Buy | $15.70 | $10.93 | n/a | 1 | Jan 3, 2025 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Upgraded: Buy | $20.80 | $32.42 | n/a | 1 | Jun 7, 2024 | |
| BNR Burning Rock Biotech | Reiterated: Buy | $8.9 → $73 | $13.63 | n/a | 4 | Sep 1, 2023 | |
| NBP NovaBridge Biosciences | Reiterated: Buy | $77 → $65 | $1.37 | n/a | 2 | Aug 31, 2022 | |
| HKG: 1530 3SBio Inc. | Reiterated: Buy | $11.87 | $13.77 | n/a | 2 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.29 | n/a | 2 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.07 | n/a | 5 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.59 | n/a | 1 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1.76 → $0.65 | $13.32 | n/a | 2 | Apr 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10.34 | $2.20 | n/a | 1 | Jun 13, 2019 |
BeOne Medicines AG
Aug 6, 2026
Reiterated: Buy
Price Target: $243.80 → $255.43
Current: $226.00
Upside: +13.02%
BeOne Medicines AG
Aug 6, 2026
Reiterated: Buy
Price Target: $402 → $423
Current: $386.46
Upside: +9.46%
Zai Lab
May 21, 2026
Reiterated: Hold
Price Target: $22 → $22
Current: $24.20
Upside: -10.74%
Hangzhou Tigermed Consulting Co., Ltd
Aug 29, 2025
Reiterated: Buy
Price Target: $38.00 → $56.00
Current: $38.56
Upside: n/a
Innovent Biologics, Inc.
Jan 3, 2025
Reiterated: Buy
Price Target: $56.90
Current: $83.60
Upside: n/a
Shanghai Pharmaceuticals Holding Co., Ltd
Jan 3, 2025
Reiterated: Buy
Price Target: $15.70
Current: $10.93
Upside: n/a
Hansoh Pharmaceutical Group Company Limited
Jun 7, 2024
Upgraded: Buy
Price Target: $20.80
Current: $32.42
Upside: n/a
Burning Rock Biotech
Sep 1, 2023
Reiterated: Buy
Price Target: $8.9 → $73
Current: $13.63
Upside: n/a
NovaBridge Biosciences
Aug 31, 2022
Reiterated: Buy
Price Target: $77 → $65
Current: $1.37
Upside: n/a
3SBio Inc.
Dec 29, 2020
Reiterated: Buy
Price Target: $11.87
Current: $13.77
Upside: n/a
Jul 30, 2020
Reiterated: Buy
Price Target: n/a
Current: $8.29
Upside: n/a
Jul 30, 2020
Reiterated: Buy
Price Target: n/a
Current: $5.07
Upside: n/a
Jul 30, 2020
Reiterated: Buy
Price Target: n/a
Current: $5.59
Upside: n/a
Apr 3, 2020
Reiterated: Sell
Price Target: $1.76 → $0.65
Current: $13.32
Upside: n/a
Jun 13, 2019
Reiterated: Buy
Price Target: $10.34
Current: $2.20
Upside: n/a